nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—CYP2D6—endogenous depression	0.771	1	CbGaD
Dextroamphetamine—SLC6A2—locus ceruleus—endogenous depression	0.0146	0.137	CbGeAlD
Dextroamphetamine—SLC6A2—sympathetic nervous system—endogenous depression	0.0115	0.108	CbGeAlD
Dextroamphetamine—SLC6A2—autonomic nervous system—endogenous depression	0.00775	0.0727	CbGeAlD
Dextroamphetamine—SLC6A3—Clearance of dopamine—COMT—endogenous depression	0.00774	0.0692	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Clearance of dopamine—MAOA—endogenous depression	0.00769	0.0688	CbGpPWpGaD
Dextroamphetamine—TAAR1—thyroid gland—endogenous depression	0.00562	0.0527	CbGeAlD
Dextroamphetamine—TAAR1—nervous system—endogenous depression	0.00473	0.0444	CbGeAlD
Dextroamphetamine—TAAR1—central nervous system—endogenous depression	0.00455	0.0427	CbGeAlD
Dextroamphetamine—TAAR1—Amine ligand-binding receptors—HTR1A—endogenous depression	0.0045	0.0402	CbGpPWpGaD
Dextroamphetamine—TAAR1—Amine ligand-binding receptors—HTR2C—endogenous depression	0.00434	0.0388	CbGpPWpGaD
Dextroamphetamine—TAAR1—Amine ligand-binding receptors—HTR7—endogenous depression	0.0038	0.034	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—endogenous depression	0.00353	0.0316	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—endogenous depression	0.00351	0.0314	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—endogenous depression	0.00308	0.0275	CbGpPWpGaD
Dextroamphetamine—SLC18A2—brainstem—endogenous depression	0.00307	0.0288	CbGeAlD
Dextroamphetamine—SLC18A2—forebrain—endogenous depression	0.00296	0.0278	CbGeAlD
Dextroamphetamine—TAAR1—Amine ligand-binding receptors—HTR2A—endogenous depression	0.00266	0.0238	CbGpPWpGaD
Dextroamphetamine—SLC6A3—brainstem—endogenous depression	0.00232	0.0218	CbGeAlD
Dextroamphetamine—TAAR1—G alpha (s) signalling events—ADM—endogenous depression	0.0023	0.0206	CbGpPWpGaD
Dextroamphetamine—SLC6A3—forebrain—endogenous depression	0.00224	0.021	CbGeAlD
Dextroamphetamine—SLC6A2—Monoamine Transport—TPH2—endogenous depression	0.00217	0.0194	CbGpPWpGaD
Dextroamphetamine—SLC18A2—adrenal gland—endogenous depression	0.00198	0.0186	CbGeAlD
Dextroamphetamine—SLC18A2—midbrain—endogenous depression	0.00195	0.0183	CbGeAlD
Dextroamphetamine—TAAR1—G alpha (s) signalling events—CRH—endogenous depression	0.00193	0.0172	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Monoamine Transport—TPH2—endogenous depression	0.00192	0.0172	CbGpPWpGaD
Dextroamphetamine—SLC18A2—thyroid gland—endogenous depression	0.00191	0.0179	CbGeAlD
Dextroamphetamine—SLC6A2—brainstem—endogenous depression	0.00187	0.0176	CbGeAlD
Dextroamphetamine—SLC6A2—forebrain—endogenous depression	0.00181	0.0169	CbGeAlD
Dextroamphetamine—SLC18A2—Synaptic Vesicle Pathway—SLC6A4—endogenous depression	0.00178	0.0159	CbGpPWpGaD
Dextroamphetamine—ADRA1A—brainstem—endogenous depression	0.00174	0.0163	CbGeAlD
Dextroamphetamine—SLC6A2—Monoamine Transport—SLC6A4—endogenous depression	0.00174	0.0155	CbGpPWpGaD
Dextroamphetamine—SLC18A2—endocrine gland—endogenous depression	0.00172	0.0161	CbGeAlD
Dextroamphetamine—ADRA1A—forebrain—endogenous depression	0.00168	0.0158	CbGeAlD
Dextroamphetamine—ADRA1B—nervous system—endogenous depression	0.00162	0.0152	CbGeAlD
Dextroamphetamine—SLC18A2—nervous system—endogenous depression	0.00161	0.0151	CbGeAlD
Dextroamphetamine—TAAR1—G alpha (s) signalling events—HTR7—endogenous depression	0.00157	0.014	CbGpPWpGaD
Dextroamphetamine—ADRA1B—central nervous system—endogenous depression	0.00156	0.0147	CbGeAlD
Dextroamphetamine—SLC18A2—Neurotransmitter Release Cycle—MAOA—endogenous depression	0.00156	0.014	CbGpPWpGaD
Dextroamphetamine—SLC18A2—central nervous system—endogenous depression	0.00155	0.0145	CbGeAlD
Dextroamphetamine—SLC6A3—Monoamine Transport—SLC6A4—endogenous depression	0.00154	0.0138	CbGpPWpGaD
Dextroamphetamine—SLC18A2—cerebellum—endogenous depression	0.00151	0.0142	CbGeAlD
Dextroamphetamine—SLC6A3—midbrain—endogenous depression	0.00148	0.0139	CbGeAlD
Dextroamphetamine—ADRA1A—cardiovascular system—endogenous depression	0.00142	0.0133	CbGeAlD
Dextroamphetamine—ADRA1B—Monoamine GPCRs—HTR1A—endogenous depression	0.00135	0.0121	CbGpPWpGaD
Dextroamphetamine—Pargyline—MAOA—endogenous depression	0.00132	0.125	CrCbGaD
Dextroamphetamine—ADRA1B—Monoamine GPCRs—HTR2C—endogenous depression	0.00131	0.0117	CbGpPWpGaD
Dextroamphetamine—ADRA1B—brain—endogenous depression	0.00124	0.0116	CbGeAlD
Dextroamphetamine—SLC18A2—brain—endogenous depression	0.00123	0.0115	CbGeAlD
Dextroamphetamine—SLC6A3—nervous system—endogenous depression	0.00121	0.0114	CbGeAlD
Dextroamphetamine—SLC6A2—adrenal gland—endogenous depression	0.00121	0.0113	CbGeAlD
Dextroamphetamine—ADRA1A—Monoamine GPCRs—HTR1A—endogenous depression	0.0012	0.0107	CbGpPWpGaD
Dextroamphetamine—SLC6A3—central nervous system—endogenous depression	0.00117	0.011	CbGeAlD
Dextroamphetamine—ADRA1A—Monoamine GPCRs—HTR2C—endogenous depression	0.00116	0.0104	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Monoamine GPCRs—HTR7—endogenous depression	0.00114	0.0102	CbGpPWpGaD
Dextroamphetamine—SLC6A3—cerebellum—endogenous depression	0.00114	0.0107	CbGeAlD
Dextroamphetamine—ADRA1B—Amine ligand-binding receptors—HTR1A—endogenous depression	0.00114	0.0102	CbGpPWpGaD
Dextroamphetamine—ADRA1A—adrenal gland—endogenous depression	0.00112	0.0105	CbGeAlD
Dextroamphetamine—ADRA1B—Amine ligand-binding receptors—HTR2C—endogenous depression	0.0011	0.00982	CbGpPWpGaD
Dextroamphetamine—SLC6A2—endocrine gland—endogenous depression	0.00105	0.00983	CbGeAlD
Dextroamphetamine—CYP2D6—brainstem—endogenous depression	0.00102	0.00961	CbGeAlD
Dextroamphetamine—ADRA1A—Monoamine GPCRs—HTR7—endogenous depression	0.00102	0.00909	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Amine ligand-binding receptors—HTR1A—endogenous depression	0.00101	0.00904	CbGpPWpGaD
Dextroamphetamine—CYP2D6—forebrain—endogenous depression	0.000989	0.00928	CbGeAlD
Dextroamphetamine—SLC6A2—nervous system—endogenous depression	0.00098	0.0092	CbGeAlD
Dextroamphetamine—ADRA1A—Amine ligand-binding receptors—HTR2C—endogenous depression	0.000975	0.00873	CbGpPWpGaD
Dextroamphetamine—ADRA1A—endocrine gland—endogenous depression	0.000974	0.00914	CbGeAlD
Dextroamphetamine—ADRA1B—Amine ligand-binding receptors—HTR7—endogenous depression	0.000962	0.0086	CbGpPWpGaD
Dextroamphetamine—SLC6A2—central nervous system—endogenous depression	0.000944	0.00885	CbGeAlD
Dextroamphetamine—SLC6A3—brain—endogenous depression	0.000929	0.00871	CbGeAlD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000919	0.00822	CbGpPWpGaD
Dextroamphetamine—ADRA1A—nervous system—endogenous depression	0.000911	0.00855	CbGeAlD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000884	0.00791	CbGpPWpGaD
Dextroamphetamine—TAAR1—G alpha (s) signalling events—POMC—endogenous depression	0.000877	0.00785	CbGpPWpGaD
Dextroamphetamine—ADRA1A—central nervous system—endogenous depression	0.000877	0.00823	CbGeAlD
Dextroamphetamine—ADRA1A—cerebellum—endogenous depression	0.000857	0.00805	CbGeAlD
Dextroamphetamine—ADRA1A—Amine ligand-binding receptors—HTR7—endogenous depression	0.000854	0.00764	CbGpPWpGaD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.000854	0.00764	CbGpPWpGaD
Dextroamphetamine—Tranylcypromine—MAOA—endogenous depression	0.000852	0.0808	CrCbGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—ADM—endogenous depression	0.000835	0.00747	CbGpPWpGaD
Dextroamphetamine—Phenylpropanolamine—MAOA—endogenous depression	0.000801	0.076	CrCbGaD
Dextroamphetamine—ADRA1B—Monoamine GPCRs—HTR2A—endogenous depression	0.000801	0.00717	CbGpPWpGaD
Dextroamphetamine—SLC6A2—brain—endogenous depression	0.000749	0.00703	CbGeAlD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.000748	0.00669	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmission across Chemical Synapses—CACNB2—endogenous depression	0.000745	0.00666	CbGpPWpGaD
Dextroamphetamine—Phentermine—MAOA—endogenous depression	0.000714	0.0677	CrCbGaD
Dextroamphetamine—ADRA1A—Monoamine GPCRs—HTR2A—endogenous depression	0.000712	0.00637	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—CRH—endogenous depression	0.000699	0.00626	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—OXT—endogenous depression	0.000699	0.00626	CbGpPWpGaD
Dextroamphetamine—ADRA1A—brain—endogenous depression	0.000696	0.00654	CbGeAlD
Dextroamphetamine—Pseudoephedrine—MAOA—endogenous depression	0.000677	0.0642	CrCbGaD
Dextroamphetamine—ADRA1B—Amine ligand-binding receptors—HTR2A—endogenous depression	0.000674	0.00603	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—HTR1A—endogenous depression	0.000673	0.00602	CbGpPWpGaD
Dextroamphetamine—Selegiline—MAOA—endogenous depression	0.000661	0.0627	CrCbGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—HTR2C—endogenous depression	0.00065	0.00582	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Amine ligand-binding receptors—HTR2A—endogenous depression	0.000598	0.00535	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Melatonin metabolism and effects—MAOA—endogenous depression	0.000586	0.00524	CbGpPWpGaD
Dextroamphetamine—Phenelzine—MAOA—endogenous depression	0.000582	0.0552	CrCbGaD
Dextroamphetamine—CYP2D6—endocrine gland—endogenous depression	0.000573	0.00538	CbGeAlD
Dextroamphetamine—SLC18A2—Neuronal System—CACNB2—endogenous depression	0.000571	0.0051	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—HTR7—endogenous depression	0.00057	0.00509	CbGpPWpGaD
Dextroamphetamine—CYP2D6—nervous system—endogenous depression	0.000537	0.00504	CbGeAlD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.000524	0.00469	CbGpPWpGaD
Dextroamphetamine—CYP2D6—central nervous system—endogenous depression	0.000517	0.00485	CbGeAlD
Dextroamphetamine—SLC6A2—NRF2 pathway—SLC6A4—endogenous depression	0.000515	0.00461	CbGpPWpGaD
Dextroamphetamine—Methamphetamine—MAOA—endogenous depression	0.000509	0.0483	CrCbGaD
Dextroamphetamine—CYP2D6—cerebellum—endogenous depression	0.000505	0.00474	CbGeAlD
Dextroamphetamine—Phenformin—CYP2D6—endogenous depression	0.000473	0.0449	CrCbGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—ADM—endogenous depression	0.000472	0.00422	CbGpPWpGaD
Dextroamphetamine—Phentermine—SLC6A4—endogenous depression	0.000461	0.0437	CrCbGaD
Dextroamphetamine—SLC6A3—NRF2 pathway—SLC6A4—endogenous depression	0.000456	0.00408	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmission across Chemical Synapses—COMT—endogenous depression	0.000451	0.00404	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmission across Chemical Synapses—MAOA—endogenous depression	0.000448	0.00401	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—CACNA1C—endogenous depression	0.000448	0.004	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmission across Chemical Synapses—CACNB2—endogenous depression	0.000444	0.00397	CbGpPWpGaD
Dextroamphetamine—Pseudoephedrine—SLC6A4—endogenous depression	0.000437	0.0414	CrCbGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—ADM—endogenous depression	0.000428	0.00383	CbGpPWpGaD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	0.000418	0.00374	CbGpPWpGaD
Dextroamphetamine—CYP2D6—brain—endogenous depression	0.00041	0.00385	CbGeAlD
Dextroamphetamine—TAAR1—GPCR ligand binding—HTR2A—endogenous depression	0.000399	0.00357	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Calcium Regulation in the Cardiac Cell—CACNA1C—endogenous depression	0.000398	0.00356	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—CRH—endogenous depression	0.000395	0.00354	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—OXT—endogenous depression	0.000395	0.00354	CbGpPWpGaD
Dextroamphetamine—Tranylcypromine—CYP2D6—endogenous depression	0.000386	0.0366	CrCbGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—HTR1A—endogenous depression	0.00038	0.0034	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—HTR2C—endogenous depression	0.000367	0.00329	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—OXT—endogenous depression	0.000359	0.00321	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CRH—endogenous depression	0.000359	0.00321	CbGpPWpGaD
Dextroamphetamine—Amphetamine—SLC6A4—endogenous depression	0.000354	0.0336	CrCbGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—OXT—endogenous depression	0.000351	0.00314	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Neuronal System—COMT—endogenous depression	0.000346	0.00309	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—HTR1A—endogenous depression	0.000346	0.00309	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Neuronal System—MAOA—endogenous depression	0.000343	0.00307	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—CACNB2—endogenous depression	0.00034	0.00304	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—HTR2C—endogenous depression	0.000334	0.00299	CbGpPWpGaD
Dextroamphetamine—Methamphetamine—SLC6A4—endogenous depression	0.000328	0.0311	CrCbGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—HTR2C—endogenous depression	0.000326	0.00292	CbGpPWpGaD
Dextroamphetamine—Phentermine—CYP2D6—endogenous depression	0.000324	0.0307	CrCbGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—HTR7—endogenous depression	0.000322	0.00288	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—POMC—endogenous depression	0.000319	0.00285	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—endogenous depression	0.000314	0.00281	CbGpPWpGaD
Dextroamphetamine—Benzyl alcohol—CYP2D6—endogenous depression	0.000312	0.0296	CrCbGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—OXT—endogenous depression	0.000312	0.00279	CbGpPWpGaD
Dextroamphetamine—Pseudoephedrine—CYP2D6—endogenous depression	0.000307	0.0291	CrCbGaD
Dextroamphetamine—Selegiline—CYP2D6—endogenous depression	0.0003	0.0284	CrCbGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—HTR7—endogenous depression	0.000292	0.00261	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—endogenous depression	0.000292	0.00261	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—HTR2C—endogenous depression	0.00029	0.00259	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—endogenous depression	0.000279	0.00249	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—WASF2—endogenous depression	0.000277	0.00247	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmission across Chemical Synapses—COMT—endogenous depression	0.000269	0.00241	CbGpPWpGaD
Dextroamphetamine—Nateglinide—CYP2D6—endogenous depression	0.000268	0.0254	CrCbGaD
Dextroamphetamine—SLC6A3—Transmission across Chemical Synapses—MAOA—endogenous depression	0.000267	0.00239	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000266	0.00238	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—WASF1—endogenous depression	0.000265	0.00237	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000261	0.00234	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—endogenous depression	0.000259	0.00232	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—ADM—endogenous depression	0.000253	0.00226	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.000252	0.00226	CbGpPWpGaD
Dextroamphetamine—Amphetamine—CYP2D6—endogenous depression	0.000249	0.0236	CrCbGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000232	0.00208	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000232	0.00207	CbGpPWpGaD
Dextroamphetamine—Methamphetamine—CYP2D6—endogenous depression	0.000231	0.0219	CrCbGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—HTR2A—endogenous depression	0.000225	0.00202	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.000224	0.002	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000224	0.002	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000221	0.00198	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.000216	0.00193	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000213	0.00191	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—OXT—endogenous depression	0.000212	0.0019	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CRH—endogenous depression	0.000212	0.0019	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—ADM—endogenous depression	0.000211	0.00189	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000206	0.00185	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—COMT—endogenous depression	0.000206	0.00184	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—HTR2A—endogenous depression	0.000205	0.00183	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—MAOA—endogenous depression	0.000205	0.00183	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HTR1A—endogenous depression	0.000204	0.00183	CbGpPWpGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—HTR2A—endogenous depression	0.0002	0.00179	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000199	0.00178	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HTR2C—endogenous depression	0.000197	0.00176	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000196	0.00175	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.000192	0.00172	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.000189	0.00169	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—ADM—endogenous depression	0.000188	0.00168	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—POMC—endogenous depression	0.00018	0.00161	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	0.000179	0.0016	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—HTR2A—endogenous depression	0.000178	0.00159	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—OXT—endogenous depression	0.000177	0.00158	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CRH—endogenous depression	0.000177	0.00158	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000173	0.00155	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HTR7—endogenous depression	0.000173	0.00154	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—HTR1A—endogenous depression	0.00017	0.00152	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.000168	0.0015	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—HTR2C—endogenous depression	0.000164	0.00147	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—POMC—endogenous depression	0.000163	0.00146	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	0.000159	0.00142	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—OXT—endogenous depression	0.000157	0.00141	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CRH—endogenous depression	0.000157	0.00141	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.000155	0.00138	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—HTR1A—endogenous depression	0.000151	0.00135	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—HTR2C—endogenous depression	0.000146	0.00131	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—HTR7—endogenous depression	0.000144	0.00129	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—COMT—endogenous depression	0.000142	0.00127	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—MAOA—endogenous depression	0.000141	0.00126	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metapathway biotransformation—COMT—endogenous depression	0.00014	0.00125	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.000137	0.00123	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.000133	0.00119	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—HTR7—endogenous depression	0.000128	0.00114	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HTR2A—endogenous depression	0.000121	0.00108	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—ADM—endogenous depression	0.000119	0.00107	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.000118	0.00105	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—ADM—endogenous depression	0.000108	0.000969	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—ADM—endogenous depression	0.000106	0.000948	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	0.000106	0.000947	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—HTR2A—endogenous depression	0.000101	0.000903	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CRH—endogenous depression	0.0001	0.000894	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—OXT—endogenous depression	0.0001	0.000894	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—POMC—endogenous depression	9.66e-05	0.000864	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—HTR1A—endogenous depression	9.63e-05	0.000861	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—ADM—endogenous depression	9.62e-05	0.000861	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	9.4e-05	0.000841	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—HTR2C—endogenous depression	9.3e-05	0.000832	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—POMC—endogenous depression	9.19e-05	0.000822	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—OXT—endogenous depression	9.08e-05	0.000812	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CRH—endogenous depression	9.08e-05	0.000812	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—HTR2A—endogenous depression	8.96e-05	0.000802	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CRH—endogenous depression	8.88e-05	0.000794	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—OXT—endogenous depression	8.88e-05	0.000794	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HTR1A—endogenous depression	8.74e-05	0.000782	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—HTR1A—endogenous depression	8.55e-05	0.000765	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HTR2C—endogenous depression	8.44e-05	0.000755	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—HTR2C—endogenous depression	8.26e-05	0.000739	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—HTR7—endogenous depression	8.14e-05	0.000728	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CRH—endogenous depression	8.07e-05	0.000721	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—OXT—endogenous depression	8.07e-05	0.000721	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—POMC—endogenous depression	8.06e-05	0.000721	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR1A—endogenous depression	7.76e-05	0.000694	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR2C—endogenous depression	7.5e-05	0.000671	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HTR7—endogenous depression	7.39e-05	0.000661	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—HTR7—endogenous depression	7.23e-05	0.000647	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—POMC—endogenous depression	7.16e-05	0.00064	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—WASF2—endogenous depression	7e-05	0.000626	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—WASF1—endogenous depression	6.71e-05	0.0006	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR7—endogenous depression	6.57e-05	0.000587	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADM—endogenous depression	6.4e-05	0.000573	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—WASF2—endogenous depression	6.22e-05	0.000556	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—WASF1—endogenous depression	5.96e-05	0.000533	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—HTR2A—endogenous depression	5.7e-05	0.00051	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADM—endogenous depression	5.69e-05	0.000509	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CRH—endogenous depression	5.36e-05	0.00048	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—OXT—endogenous depression	5.36e-05	0.00048	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—TPH1—endogenous depression	5.29e-05	0.000474	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HTR2A—endogenous depression	5.18e-05	0.000463	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR1A—endogenous depression	5.16e-05	0.000462	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—HTR2A—endogenous depression	5.07e-05	0.000453	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR2C—endogenous depression	4.99e-05	0.000446	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CRH—endogenous depression	4.76e-05	0.000426	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—OXT—endogenous depression	4.76e-05	0.000426	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR2A—endogenous depression	4.6e-05	0.000411	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR1A—endogenous depression	4.59e-05	0.00041	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—POMC—endogenous depression	4.55e-05	0.000407	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR2C—endogenous depression	4.43e-05	0.000396	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR7—endogenous depression	4.37e-05	0.000391	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—POMC—endogenous depression	4.14e-05	0.00037	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—POMC—endogenous depression	4.05e-05	0.000362	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—TPH2—endogenous depression	4.01e-05	0.000359	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CACNB2—endogenous depression	4.01e-05	0.000359	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—DPYD—endogenous depression	3.95e-05	0.000353	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR7—endogenous depression	3.88e-05	0.000347	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—POMC—endogenous depression	3.67e-05	0.000329	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CACNA1C—endogenous depression	3.67e-05	0.000328	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR2A—endogenous depression	3.06e-05	0.000274	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR2A—endogenous depression	2.72e-05	0.000243	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—POMC—endogenous depression	2.44e-05	0.000219	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—COMT—endogenous depression	2.43e-05	0.000217	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MAOA—endogenous depression	2.41e-05	0.000216	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—POMC—endogenous depression	2.17e-05	0.000194	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—POMC—endogenous depression	1.57e-05	0.000141	CbGpPWpGaD
